Improving Vitamin D Status In Cystic Fibrosis

Completed · Not applicable

Conditions studied: Cystic Fibrosis

In brief

The purpose of this study is to establish an effective method to correct vitamin D deficiency in subjects with cystic fibrosis. The investigators will examine cholecalciferol, ergocalciferol and UV light.

Key facts

Study ID

NCT00450073

Run by

Atlanta VA Medical Center

People needed

30

Starts

2006-11-01

Expected to finish

2011-05-01

Last updated by the study team

2014-02-21

Who can join

Age: 18 and older, up to 60. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subjects seen initially at the Emory CF center between the months of September and December
• Age > 16, both males and females, confirmed cystic fibrosis by genetic testing or sweat testing, FEV1 > 40%.

You may not qualify if…

• History of lung transplant or awaiting lung transplantation
• Current hospitalization or greater than 6 hospitalizations/year
• History of malignancy, renal disease (calculated GFR < 50% reduced from normal), liver disease (AST or AST > 3 times upper limit of normal), greater than 10 mg of prednisone or equivalent, hypercalcemia
• History of easily burned skin after sunlight exposure, taking medications with may cause photosensitivity
• History of skin cancer or multiple moles or family history of skin cancer
• Moderate to severe vitamin D deficiency (25(OH)D ≤ 15 ng/ml).

Where it is running

• Emory CF Center — Atlanta, Georgia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.